Anonymous: "A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)", , 18 June 2012 (2012-06-18), XP055497221, Retrieved from the Internet: URL:https://clinicaltrials.gov/ct2/show/NC T01621178 [retrieved on 2018-08-03] (B1)

K R TUTTLE ET AL: "Comparable glycaemic control with once weekly dulaglutide versus insulin glargine, both combined with lispro, in type 2 diabetes and chronic kidney disease (AWARD-7)", DIABETOLOGIA, vol. 60, no. Suppl. 1, 11 September 2017 (2017-09-11), page S3, XP055497178, BERLIN, DE ISSN: 0012-186X, DOI: 10.1007/s00125-017-4350-z (B1)

KATHERINE R TUTTLE ET AL: "Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial", THE LANCET / DIABETES & ENDOCRINOLOGY, vol. 6, no. 8, 1 August 2018 (2018-08-01), pages 605-617, XP055497169, UK ISSN: 2213-8587, DOI: 10.1016/S2213-8587(18)30104-9 (B1)

WO-A1-2011/138421 (B1)

LILI TONG ET AL: "Glycemic control of type 2 diabetes mellitus across stages of renal impairment: information for primary care providers", POSTGRADUATE MEDICINE., vol. 130, no. 4, 19 May 2018 (2018-05-19), pages 381-393, XP055497193, US ISSN: 0032-5481, DOI: 10.1080/00325481.2018.1457397 (B1)

MELANIE DAVIES ET AL: "The treatment of type 2 diabetes in the presence of renal impairment: what we should know about newer therapies", CLINICAL PHARMACOLOGY: ADVANCES AND APPLICATIONS, vol. 8, 23 June 2016 (2016-06-23), pages 61-81, XP055497212, DOI: 10.2147/CPAA.S82008 (B1)

KATHERINE R. TUTTLE ET AL: "Effects of once-weekly dulaglutide on kidney function in patients with type 2 diabetes in phase II and III clinical trials", DIABETES, OBESITY AND METABOLISM, vol. 19, no. 3, 23 November 2016 (2016-11-23), pages 436-441, XP055497173, ISSN: 1462-8902, DOI: 10.1111/dom.12816 cited in the application (B1)